Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
July 6, 1984
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin]
P Drings, P Stiefel, H P Dirks, et al.
Onkologie
|
August 1, 1990
[Requirements in clinical evaluation of drugs in oncology. Guidelines of the phase I/II study group of the Professional Society of Internal Oncology of the German Cancer Society]
W Queisser, R Hermann, L Edler, et al.
British Journal of Haematology
|
February 5, 1998
Should a platelet limit of 600 x 10(9)/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages
E Lengfelder, A Hochhaus, U Kronawitter, et al.
Onkologie
|
February 1, 1988
[Induction and intensive combined therapy of acute myeloid leukemia in adults]
E Kurrle, G Ehninger, M Freund, et al.
Onkologie
|
February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society
K Possinger, H Wagner, P Worst, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 22, 1984
[Prospective randomized study in advanced stomach cancer. Comparison between combinations of 5-fluorouracil and carmustine without and with adriamycin]
W Queisser, G Schnitzler, M E Heim, et al.
Onkologie
|
June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"
U Räth, H Flechtner, J Selbach, et al.
Blut
|
May 1, 1988
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia
E Kurrle, G Ehninger, M Freund, et al.
Cancer Treatment Reports
|
April 1, 1986
Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer
G Schnitzler, W Queisser, M E Heim, et al.
Blood
|
July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Deutsche Medizinische Wochenschrift (1946)
|
July 6, 1984
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin]
P Drings, P Stiefel, H P Dirks, et al.
Onkologie
|
August 1, 1990
[Requirements in clinical evaluation of drugs in oncology. Guidelines of the phase I/II study group of the Professional Society of Internal Oncology of the German Cancer Society]
W Queisser, R Hermann, L Edler, et al.
British Journal of Haematology
|
February 5, 1998
Should a platelet limit of 600 x 10(9)/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages
E Lengfelder, A Hochhaus, U Kronawitter, et al.
Onkologie
|
February 1, 1988
[Induction and intensive combined therapy of acute myeloid leukemia in adults]
E Kurrle, G Ehninger, M Freund, et al.
Onkologie
|
February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society
K Possinger, H Wagner, P Worst, et al.
Deutsche Medizinische Wochenschrift (1946)
|
June 22, 1984
[Prospective randomized study in advanced stomach cancer. Comparison between combinations of 5-fluorouracil and carmustine without and with adriamycin]
W Queisser, G Schnitzler, M E Heim, et al.
Onkologie
|
June 1, 1990
Etoposide, adriamycin, and cisplatinum (EAP) combination chemotherapy for advanced gastric cancer. A phase II trial by the "Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)"
U Räth, H Flechtner, J Selbach, et al.
Blut
|
May 1, 1988
A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia
E Kurrle, G Ehninger, M Freund, et al.
Cancer Treatment Reports
|
April 1, 1986
Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer
G Schnitzler, W Queisser, M E Heim, et al.
Blood
|
July 15, 1993
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group
R Hehlmann, H Heimpel, J Hasford, et al.
Page
of 13